Abstract
Nearly 13 years ago, the publication of results from the ARDS Network's ARMA trial revealed an 8.8% absolute mortality reduction in patients with acute lung injury (ALI)/ARDS receiving a low tidal volume ventilation strategy.[1][1] One might have guessed at the time that such unambiguous benefit
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
